Equitable Mackenzie Ivy Canadian Balanced
October 31, 2025
Fund Overview
The objective of the segregated fund is to invest in units of the Mackenzie Ivy Canadian Balanced Fund or a substantially similar fund. The underlying fund objective is to seek capital growth and current income by investing primarily in a combination of Canadian equities and fixed-income securities.
Risk Rating
This fund's risk rating is Low to Medium
As of August 31, 2025
Top 10 Holdings (%)
As of August 31, 2025
Growth of $10,000
As of October 31, 2025
For the period 04/30/2017 through 10/31/2025 with $10,000 CAD investment, The value of the investment would be $15,276
Calendar Return (%)
As of October 31, 2025
| Period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 13.18 | 9.86 | -6.03 | 14.21 | -2.37 | 13.34 | -7.17 | - | - | - |
| Quartile | 2 | 2 | 2 | 2 | 4 | 3 | 3 | - | - | - |
Compound Return (%)
As of October 31, 2025
| Period | 1 mth | 3 mths | 6 mths | 1 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|---|---|
| Fund | 0.24 | 3.59 | 8.83 | 10.43 | 10.94 | 9.29 | - |
| Quartile | 3 | 3 | 3 | 3 | 2 | 2 | - |
Fund Information
| Description | Guarantee Fee | NL | NL-CB | NL-CB5 | DSC | LL |
|---|---|---|---|---|---|---|
| Investment Class (75/75) | - | ELC754 | ELC3054 | ELC5054 | ELC654 | ELC1254 |
| Estate Class (75/100) | 0.30% | ELC954 | ELC3154 | ELC5154 | ELC854 | ELC1354 |
| Protection Class (100/100) | 0.60% | ELC1154 | ELC3254 | ELC5254 | ELC1054 | ELC1454 |
| Available for new sales | Not available for new sales | |||||
Other Fund Information
Product Availabilty
Pivotal Select (75/75, 75/100, 100/100)
Date of Inception:
May 2017
Net Asset Value per Unit:
$15.34 (11/13/2025)
Change: -$0.12 (-0.81%)
Estimated Management
Expense Ratio (MER)†:
2.84%
Fund Category
Canadian Equity Balanced
Portfolio Manager
Mackenzie Financial Corporation
Investment Style
Equity
Market Capitalization: Large
Fund Style: Growth
Fixed Income
Duration: Mid
Credit Rating: Med
Performance Chart
Summary
For the period 04/30/2017 through 10/31/2025 with $10,000 CAD investment
Total returns performance
52.76%
Last price
$15.28 CAD
as of market close 10/31/2025
Value of $10,000 investment
$15,276.25 CAD